The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
Although suppliers and providers may hesitate at a partnership approach, it is possible to collaborate on total cost of ownership. Learn from the…
Book
AHRMM created this book for engaged and motivated supply chain leaders in the making.
Webcast
This video reviews the benefits of RFID implementation, and the successes and lessons learned from a local medical center.
On-Demand Educational Webinars
Resiliency in the operating room is imperative in today’s health care climate. A well-functioning OR has the potential to increase the number of…
Podcasts
As UDI capture and exchange becomes more prevalent across the healthcare ecosystem and as implantable device information is linked to patient outco